Page last updated: 2024-11-04
tegafur and Necrosis
tegafur has been researched along with Necrosis in 9 studies
Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized controlled trial was conducted to determine whether pathologic necrosis in response to preoperative treatment with uracil-tegafur(UFT) could be used to identify patients with colorectal cancer most likely to benefit from postoperative adjuvant therapy with the drug." | 9.13 | Clinical identification of colorectal cancer patients benefiting from adjuvant uracil-tegafur (UFT): a randomized controlled trial. ( Fujii, M; Kochi, M; Takayama, T, 2008) |
| " Here, we report the case of a patient with systemic sclerosis who developed severe digital ischemia during combination gemcitabine/S-1 chemotherapy for pancreatic cancer." | 7.77 | A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis. ( Chiba, T; Ishikawa, S; Kanai, M; Kawaguchi, Y; Masui, T; Matsumoto, S; Mimori, T; Mori, Y; Nishimura, T; Yanagihara, K; Zaima, C, 2011) |
| "A randomized controlled trial was conducted to determine whether pathologic necrosis in response to preoperative treatment with uracil-tegafur(UFT) could be used to identify patients with colorectal cancer most likely to benefit from postoperative adjuvant therapy with the drug." | 5.13 | Clinical identification of colorectal cancer patients benefiting from adjuvant uracil-tegafur (UFT): a randomized controlled trial. ( Fujii, M; Kochi, M; Takayama, T, 2008) |
| "This study was designed to determine if histopathologic evaluation of patients with resectable colorectal cancer following preoperative chemotherapy with uracil and tegafur with a molar ratio of 4:1 (UFT) could predict chemosensitivity to postoperative fluoropyrimidines to prevent recurrence of disease." | 5.09 | Using preoperative UFT to predict sensitivity to fluoropyrimidines in colorectal cancer. ( Fujii, M, 1999) |
| " Here, we report the case of a patient with systemic sclerosis who developed severe digital ischemia during combination gemcitabine/S-1 chemotherapy for pancreatic cancer." | 3.77 | A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis. ( Chiba, T; Ishikawa, S; Kanai, M; Kawaguchi, Y; Masui, T; Matsumoto, S; Mimori, T; Mori, Y; Nishimura, T; Yanagihara, K; Zaima, C, 2011) |
| "Tegafur was administered for 24 weeks at respective doses of 90 mg, 120 mg and 150 mg/kg/day." | 1.27 | [Maximum tolerated dose of tegafur in rats]. ( Aoki, N; Hamada, S; Hirayama, R; Matsumura, J; Mishima, Y; Miyanaga, T; Takagi, Y, 1984) |
| "A case of an amylase-producing ovarian cancer in 69-year-old woman has been investigated by light and electron microscopy, as well as by amylase isozyme analysis." | 1.27 | [Amylase-producing ovarian cancer treated with postoperative QF chemotherapy--a case report]. ( Chiba, T; Hiura, M; Kaneko, H; Kawamurra, S; Moriwaki, S; Tanaka, M; Yokoyama, T, 1988) |
Research
Studies (9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Fujii, M | 3 |
| Takayama, T | 1 |
| Kochi, M | 2 |
| Zaima, C | 1 |
| Kanai, M | 1 |
| Ishikawa, S | 1 |
| Kawaguchi, Y | 1 |
| Masui, T | 1 |
| Mori, Y | 1 |
| Nishimura, T | 1 |
| Matsumoto, S | 1 |
| Yanagihara, K | 1 |
| Chiba, T | 2 |
| Mimori, T | 1 |
| Ueda, H | 1 |
| Tanaka, H | 1 |
| Kida, Y | 1 |
| Fukuchi, H | 1 |
| Ichinose, M | 1 |
| Hirayama, R | 1 |
| Hamada, S | 1 |
| Matsumura, J | 1 |
| Takagi, Y | 1 |
| Miyanaga, T | 1 |
| Aoki, N | 1 |
| Mishima, Y | 1 |
| Sommer, H | 1 |
| Meinhold, P | 1 |
| Wakabayashi, K | 1 |
| Konomi, K | 1 |
| Yamagata, M | 1 |
| Iwai, S | 1 |
| Tanaka, T | 1 |
| Kawamurra, S | 1 |
| Hiura, M | 1 |
| Kaneko, H | 1 |
| Yokoyama, T | 1 |
| Tanaka, M | 1 |
| Moriwaki, S | 1 |
| Seki, S | 1 |
| Mizoguchi, Y | 1 |
| Saito, S | 1 |
| Shiomi, S | 1 |
| Sakagami, Y | 1 |
| Sakaguchi, H | 1 |
| Kuroki, T | 1 |
| Harihara, S | 1 |
| Kobayashi, K | 1 |
| Monna, T | 1 |
Trials
3 trials available for tegafur and Necrosis
| Article | Year |
|---|---|
Clinical identification of colorectal cancer patients benefiting from adjuvant uracil-tegafur (UFT): a randomized controlled trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2008 |
Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Combined Mo | 2008 |
Using preoperative UFT to predict sensitivity to fluoropyrimidines in colorectal cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, | 1999 |
Other Studies
6 other studies available for tegafur and Necrosis
| Article | Year |
|---|---|
A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine | 2011 |
[Maximum tolerated dose of tegafur in rats].
Topics: Administration, Oral; Animals; Body Weight; Drug Administration Schedule; Drug Tolerance; Fluorourac | 1984 |
[The problem of accidental paravenous application of cytostatics--case history (author's transl)].
Topics: Antineoplastic Agents; Cyclophosphamide; Cystadenoma; Doxorubicin; Female; Humans; Infusions, Parent | 1981 |
[A case of colon cancer with severe anal bleeding caused in a preoperative chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Adult; Anal Canal; Antineoplastic Combined Chemotherapy Protoc | 1991 |
[Amylase-producing ovarian cancer treated with postoperative QF chemotherapy--a case report].
Topics: Amylases; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma; Female; Humans; Middle | 1988 |
[A clinicopathological study of 11 patients with acute drug-induced hepatic failure].
Topics: Acute Disease; Adult; Aged; Chemical and Drug Induced Liver Injury; Ethionamide; Female; Halothane; | 1986 |